OVID Ovid Therapeutics Inc

Ovid Therapeutics Inc is a US-based biopharmaceutical company. The firm is engaged primarily in developing medicines for patients suffering with rare neurological disorders.

$4.46  -0.04 (-0.78%)
As of 06/14/2021 15:59:44 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  05/05/2017
Outstanding shares:  67,807,266
Average volume:  814,900
Market cap:   $302,420,406
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    690469101
ISIN:        US6904691010
Sedol:      BYPFK63
Valuation   (See tab for details)
PE ratio:   2.21
PB ratio:   1.38
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy